{
  "paper": "a2678e62ba9698a7e9bac0b0b5c0552d.txt",
  "words": 3027,
  "extractions": {
    "title": {
      "value": "Dosimetry of [18F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans",
      "justification": "The title of the paper extracted from the given text",
      "quote": "Dosimetry of [18F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans"
    },
    "description": "This research paper presents dosimetry data for [18F]TRACK, the first PET radioligand for TrkB/C, in healthy humans, highlighting its biodistribution, organ-specific doses, and total effective dose.",
    "type": {
      "value": "Empirical study",
      "justification": "The paper involves the collection and analysis of dosimetry data for the [18F]TRACK radiotracer in human subjects, which is characteristic of empirical research.",
      "quote": "Here we report dosimetry data for [18F]TRACK in healthy humans."
    },
    "primary_research_field": {
      "name": {
        "value": "Medical Imaging",
        "justification": "The primary focus of the paper is on the usage of PET imaging to study the TrkB/C receptors in humans.",
        "quote": "[18F]TRACK is the first PET radioligand for TrkB/C with proven in vivo brain penetration and on-target specific signal."
      },
      "aliases": [
        "Medical Imaging"
      ]
    },
    "sub_research_fields": [
      {
        "name": {
          "value": "Radiology",
          "justification": "The study involves radiological methods related to PET/CT imaging and dosimetry of the radiotracer.",
          "quote": "6 healthy participants (age 22–61 y, 3 female) were scanned on a General Electric Discovery PET/CT 690 scanner."
        },
        "aliases": [
          "Radiology"
        ]
      },
      {
        "name": {
          "value": "Neurology",
          "justification": "The paper focuses on imaging TrkB/C receptors, which are relevant in the context of neurological conditions like Alzheimer's disease.",
          "quote": "Reduced expression or abnormal and impaired signalling of Trk receptors are found in a vast spectrum of disorders and pathologies, such as ischemic stroke, Alzheimer’s disease (AD) and others."
        },
        "aliases": [
          "Neurology"
        ]
      },
      {
        "name": {
          "value": "Nuclear Medicine",
          "justification": "The use of PET tracers and radioligands indicates that the study is also related to the field of Nuclear Medicine.",
          "quote": "Dosimetry of [18F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans"
        },
        "aliases": [
          "Nuclear Medicine"
        ]
      }
    ],
    "models": [
      {
        "name": {
          "value": "[18F]TRACK",
          "justification": "[18F]TRACK is the main subject of study as a PET radioligand for imaging TrkB/C receptors.",
          "quote": "[18F]TRACK is the first PET radioligand for TrkB/C with proven in vivo brain penetration and on-target specific signal."
        },
        "aliases": [
          "[18F]TRACK"
        ],
        "is_contributed": {
          "value": 1,
          "justification": "The paper presents original research and dosimetry data on [18F]TRACK, thus contributing this model to the field.",
          "quote": "We developed [18F]TRACK, an 18F-derivative of [11C]-(R)-IPMICF16, displaying significantly reduced P-gp-liability, brain off-target selectivity, and favorably adjusted binding affinity in TrkB/C rich regions."
        },
        "is_executed": {
          "value": 0,
          "justification": "The study does not mention any specific use of GPU or CPU for executing [18F]TRACK, as the focus is on PET imaging and radiotracer distribution.",
          "quote": "[18F]TRACK was synthesized with high molar activities (Am = 250 ± 75 GBq/µmol)..."
        },
        "is_compared": {
          "value": 0,
          "justification": "The study does not compare [18F]TRACK numerically with other models but rather focuses on its dosimetry and biodistribution.",
          "quote": "The objective of this study was to provide dosimetry data for [18F]TRACK in humans."
        },
        "referenced_paper_title": {
          "value": "First-in-human brain imaging of [18F]TRACK, a PET tracer for tropomyosin receptor kinases",
          "justification": "This referenced paper appears to be an earlier study related to the initial human brain imaging of [18F]TRACK.",
          "quote": "Bailey JJ, Kaiser L, Lindner S, Wust M, Thiel A, Soucy JP, et al. First-in-human brain imaging of [(18)F]TRACK, a PET tracer for tropomyosin receptor kinases."
        }
      }
    ],
    "datasets": [],
    "libraries": []
  },
  "usage": {
    "completion_tokens": 927,
    "prompt_tokens": 7297,
    "total_tokens": 8224
  }
}